BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Radiol. Jul 28, 2026; 18(7): 120526
Published online Jul 28, 2026. doi: 10.4329/wjr.120526
Figure 1
Figure 1 Typical magnetic resonance imaging appearance of branch-duct intraductal papillary mucinous neoplasm. A: Axial T2-weighted image shows a cystic lesion in the pancreatic head; B: Magnetic resonance cholangiopancreatography maximum intensity projection reconstruction demonstrates multiple cystic lesions scattered throughout the pancreatic parenchyma, appearing to communicate with the main pancreatic duct, which is of normal caliber; C: Thick-slab magnetic resonance cholangiopancreatography better depicts communication between the largest cystic lesion and the pancreatic ductal system (arrow).
Figure 2
Figure 2 Main-duct intraductal papillary mucinous neoplasm with segmental duct dilatation. A: Thick-slab magnetic resonance cholangiopancreatography shows an abrupt change in the caliber of the main pancreatic duct without interruption; the duct appears homogeneously hyperintense; B and C: Axial fat-suppressed T2-weighted images demonstrate no mural nodules or solid components and no flow-void artifacts suggestive of calculi, excluding an obstructive cause of dilatation.
Figure 3
Figure 3 Mixed-type intraductal papillary mucinous neoplasm with segmental main duct dilatation. A and B: Coronal single-shot T2-weighted images show irregular cystic dilatation of the main pancreatic duct in the pancreatic head, with involvement of multiple side branches; C: Thick-slab magnetic resonance cholangiopancreatography provides a comprehensive depiction of the lesion morphology; D: Thin-slab magnetic resonance cholangiopancreatography highlights the site of abrupt caliber change of the main pancreatic duct (arrow) without endoluminal signal interruption.
Figure 4
Figure 4 Atypical unilocular intraductal papillary mucinous neoplasm. A: Thick-slab magnetic resonance cholangiopancreatography demonstrates a predominantly unilocular cystic lesion with subtle caudal septations located adjacent to the main pancreatic duct. This appearance may mimic a mucinous cystic neoplasm, posing a diagnostic challenge; B: Axial single-shot T2-weighted image shows segmental dilatation of the main pancreatic duct in the isthmus and body, with preserved upstream ductal caliber; C: Thin-slab magnetic resonance cholangiopancreatography confirms direct communication between the cystic lesion and the main pancreatic duct (arrow), establishing the diagnosis of intraductal papillary mucinous neoplasm.
Figure 5
Figure 5 Mixed-type intraductal papillary mucinous neoplasm associated with intrapancreatic lipoma. A and B: Axial single-shot T2-weighted images show a well-defined intrapancreatic lipoma (arrow) exerting mass effect on the adjacent duodenum and on multiple cystic dilatations; C: Post-contrast T1-weighted image demonstrates compressed cystic lesions in the pancreatic head and uncinate process, raising differential diagnostic considerations between branch-duct intraductal papillary mucinous neoplasm and microcystic serous cystadenoma; D: Magnetic resonance cholangiopancreatography maximum intensity projection reconstruction confirms direct communication between the cystic dilatations and the main pancreatic duct, supporting the diagnosis of mixed-type intraductal papillary mucinous neoplasm (histologically confirmed).
Figure 6
Figure 6 Typical magnetic resonance imaging appearance of serous cystic neoplasm. A: Magnetic resonance cholangiopancreatography maximum intensity projection reconstruction shows a large microcystic lesion in the pancreatic tail; B and C: Coronal and axial single-shot T2-weighted images demonstrate a markedly hyperintense microcystic mass with thin septa converging toward a central scar; D and E: Pre-contrast and post-contrast T1-weighted images show a hypointense lesion with delayed enhancement of the central scar; F: Non-contrast computed tomography better depictes central scar calcification (arrow); G and H: Diffusion weighted imaging (b = 1000 second/mm2) shows mild hyperintensity on high b values due to T2 shine-through, as confirmed on apparent diffusion coefficient (ADC) map, which presents hyperintense signal, indicating absence of true restriction, and high ADC value (ADC = 3.2 × 10-3 mm2/second).
Figure 7
Figure 7 Uniloculated serous cystic neoplasm. A: Axial single-shot T2-weighted image represents a reference example of the typical magnetic resonance appearance of serous cystic neoplasm; B: Axial single-shot T2-weighted image shows a cystic lesion in the pancreatic tail; C: Magnetic resonance cholangiopancreatography thick-slab demonstrates a predominantly unilocular morphology with subtle internal septations and no definite communication with the main pancreatic duct; D and E: Diffusion weighted imaging (b = 1000 second/mm2) shows mild hyperintensity on high b values due to T2 shine-through (arrow), without true diffusion restriction, as confirmed on apparent diffusion coefficient map, which demonstrates no signal drop, with hyperintense signal indicating absence of true restriction; F and G: Pre-contrast and post-contrast T1-weighted images depict a hypointense lesion with minimal peripheral enhancement. This appearance may mimic a mucinous cystic neoplasm.
Figure 8
Figure 8 Giant serous cystic neoplasm. Magnetic resonance cholangiopancreatography thick-slab shows a giant micro-cystic/macro-cystic lesion (15 cm) in the pancreatic head, causing displacement of the duodenum.
Figure 9
Figure 9 Solid serous cystic neoplasm. A and B: Contrast-enhanced computed tomography shows a well-defined hypervascular lesion in the pancreatic head with arterial phase hyperenhancement and portal venous phase isointensity, measuring approximately 2 cm; C: Axial single-shot T2-weighted image represents a reference example of the typical magnetic resonance appearance of serous cystic neoplasm; D: Axial single-shot T2-weighted image demonstrates a moderately and heterogeneously hyperintense lesion; E: Axial T1-weighted image shows low signal intensity; F and G: Diffusion weighted imaging (b = 1000 second/mm2) shows high signal intensity due to T2 shine-through, without true diffusion restriction, as confirmed on apparent diffusion coefficient map, which demonstrates no signal drop, with isointense signal indicating absence of true restriction (arrow). This appearance may mimic a pancreatic neuroendocrine tumor.
Figure 10
Figure 10  Serous cystic neoplasm with intratumoral hemorrhage. A: Coronal single-shot T2-weighted image shows a markedly hyperintense microcystic lesion in the pancreatic tail with an associated macrocystic component; B: Axial single-shot T2-weighted image demonstrates a dependent hypointense layer within the macrocyst (arrow), consistent with sedimented hemorrhagic products; C and D: Diffusion weighted imaging (b = 1000 second/mm2) shows no true diffusion restriction, with minimal dependent hyperintensity (arrow) related to hemorrhagic debris. On apparent diffusion coefficient (ADC) maps, the lesion appears predominantly hyperintense with a small dependent hypointense component, at the level of which a high ADC value (ADC = 2.27 × 10-3 mm2/second) confirms the absence of true diffusion restriction and supports hemorrhagic content rather than a solid component; E and F: Pre-contrast and post-contrast T1-weighted images show intrinsic T1 hyperintensity of the macrocyst and delayed septal enhancement, without enhancement of the hemorrhagic component; G: Magnetic resonance cholangiopancreatography thick-slab confirms the microcystic architecture and relative hypointensity of the macrocystic component due to intracystic hemorrhage.
Figure 11
Figure 11  Disseminated form of serous cystic neoplasm. A: Magnetic resonance cholangiopancreatography maximum intensity projection reconstruction shows marked pancreatic enlargement with complete replacement by innumerable microcysts exhibiting very high T2 signal intensity; B: Axial single-shot T2-weighted image demonstrates a markedly hyperintense microcystic mass with thin septa converging toward a central scar at the level of the pancreatic head (arrow).
Figure 12
Figure 12  Von Hippel-Lindau disease with multiple serous cystic neoplasms. A: Thick-slab magnetic resonance cholangiopancreatography shows multiple cystic lesions diffusely involving the pancreas; B: Axial T2-weighted image demonstrates numerous markedly hyperintense cysts of variable size scattered throughout the pancreatic parenchyma; C: Contrast-enhanced T1-weighted image shows multiple cystic lesions with delayed peripheral and septal enhancement without communication with the main pancreatic duct.
Figure 13
Figure 13  Typical magnetic resonance imaging appearance of mucinous cystic neoplasm. A and B: Coronal and axial T2-weighted images show a well-defined unilocular cystic lesion in the pancreatic tail, with homogeneous high signal intensity and smooth margins; C: Axial T1-weighted image demonstrates homogeneous low signal intensity of the cystic content, without intrinsic T1 hyperintensity suggestive of hemorrhagic or proteinaceous material; D: Diffusion weighted imaging (b = 1000 second/mm2) shows no diffusion restriction within the lesion; E: Post-contrast T1-weighted image shows no enhancing mural nodules and no internal solid components.
Figure 14
Figure 14  Small mucinous cystic neoplasm. A and B: Axial and coronal T2-weighted images show a small (< 3 cm), well-circumscribed cystic lesion in the pancreatic body–tail region, with homogeneous high T2 signal intensity and subtle internal septations; C: Thick-slab magnetic resonance cholangiopancreatography demonstrates a unilocular cystic morphology without communication with the main pancreatic duct; D: Diffusion weighted imaging (b = 1000 second/mm2) shows no evidence of diffusion restriction, with mild hyperintensity of the cyst wall; E: Axial T1-weighted image shows low signal intensity, without intrinsic T1 hyperintensity; F and G: Post-contrast T1-weighted images depict minimal enhancement of thin internal septa, without enhancing mural nodules.
Figure 15
Figure 15  Mucinous cystic neoplasm with “cyst-within-cyst” architecture. A and B: Coronal and axial single-shot T2-weighted images show a well-defined cystic lesion containing multiple internal cystic components with heterogeneous fluid signal; C: Thick-slab magnetic resonance cholangiopancreatography demonstrates a normal-caliber main pancreatic duct without communication with the cystic lesion; D: Axial T1-weighted image confirms intracystic heterogeneity, with focal hyperintense areas suggestive of hemorrhagic or proteinaceous content; E and F: Post-contrast axial T1-weighted images show minimal enhancement of the thin intracystic septa; G: Non-contrast computed tomography demonstrates peripheral (mural) and intraseptal calcifications. The “cyst-within-cyst” appearance may enter the differential diagnosis with hydatid cyst.
Figure 16
Figure 16  Typical magnetic resonance imaging appearance of solid pseudopapillary neoplasm. A: Non-contrast computed tomography shows a heterogeneous lesion with small internal calcifications (arrow) of the pancreatic head; B: Axial single-shot T2-weighted image demonstrates a predominantly hyperintense mass with internal heterogeneity related to cystic and solid areas; C: Axial T1-weighted image shows intrinsic areas of high signal intensity consistent with hemorrhagic components; D and E: Axial post contrast-enhanced T1-weighted images in arterial and portal-venous phases, demonstrate progressive heterogeneous enhancement of the solid portions; F: Coronal post contrast-enhanced T1-weighted image confirms the encapsulated appearance and mixed solid-cystic architecture.
Figure 17
Figure 17  Atypical small solid variant of solid pseudopapillary neoplasm. A: Axial T2-weighted image shows a small, well-defined solid lesion with mildly hyperintense signal in the pancreatic body; B: Axial T1-weighted image demonstrates low signal intensity; C: Thin-slab magnetic resonance cholangiopancreatography shows only poor hyperintensity (arrow), reflecting the predominantly solid nature of the lesion; D: Diffusion weighted imaging (b = 1000 second/mm2) demonstrates high hyperintensity on high b values (arrow). In a 34-year-old woman, this homogeneous solid appearance represents an atypical presentation of solid pseudopapillary neoplasm and may mimic a pancreatic neuroendocrine tumor.
Figure 18
Figure 18  Atypical solid pseudopapillary tumor with extensive hemorrhagic cystic component. A: Axial T2-weighted image shows a well-defined heterogeneous mass in the pancreatic head, characterized by a large hyperintense cystic component with internal fluid–fluid level, consistent with hemorrhagic sedimentation; B: Axial T1-weighted magnetic resonance image demonstrates intrinsic high signal intensity of the cystic component, consistent with intralesional hemorrhage; C: Thin-slab magnetic resonance cholangiopancreatography confirms the presence of cystic components (arrow) within the lesion, without evidence of communication with the main pancreatic duct; D and E: Diffusion weighted imaging (b = 1000 second/mm2) shows high signal intensity of the solid components, with true diffusion restriction, confirmed by apparent diffusion coefficient (ADC) map which demonstrates moderate signal drop, and low ADC value (ADC = 1.42 × 10-3 mm2/second).
Figure 19
Figure 19  Large solid pseudopapillary neoplasm with spontaneous rupture and hemoperitoneum. A and B: Axial and coronal T2-weighted images show a large heterogeneous pancreatic mass with mixed solid and cystic components and extensive intralesional hemorrhage; C and D: Axial and coronal T1-weighted images demonstrate intrinsic high signal intensity consistent with blood products; E and F: Axial post-contrast T1-weighted images show heterogeneous enhancement of the viable solid portions with non-enhancing hemorrhagic areas; G and H: Coronal post-contrast T1-weighted images confirm capsular disruption (arrow) with adjacent fluid collections consistent with hemoperitoneum. In a 16-year-old boy, these findings are consistent with spontaneous rupture of solid pseudopapillary neoplasm complicated by intra-tumoral hemorrhage and hemoperitoneum.


Write to the Help Desk